Ghana vs Philippines: Contraceptive prevalence, any modern method
Contraceptive prevalence, any modern method over time
- Ghana
- Philippines
How they compare
Philippines currently reports 24.3% against 23.4% in Ghana, a difference of 0.9%.
Across all 8 years both countries report, Philippines has been ahead every year.
Ghana ranks 46th and Philippines ranks 43rd of 62 countries.
Philippines has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Ghana | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 10.2% | 17.1% | 6.9% | Philippines |
| 2000s | 14.4% | 21.7% | 7.3% | Philippines |
| 2010s | 17.6% | 24.2% | 6.6% | Philippines |
| 2020s | 23.4% | 24.3% | 0.9% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher contraceptive prevalence, any modern method, Ghana or Philippines?
- Philippines, at 24.3% against 23.4% in Ghana as of 2022.
- What is the difference in contraceptive prevalence, any modern method between Ghana and Philippines?
- 0.9%, with Philippines ahead.
- How many years of comparable data are there for Ghana and Philippines?
- 8 years are reported by both, from 1993 to 2022.
- How do Ghana and Philippines rank globally for contraceptive prevalence, any modern method?
- Ghana ranks 46th and Philippines ranks 43rd of 62 countries.
- Where does this data come from?
- Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as Contraceptive prevalence, any modern method (% of all women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Contraceptive prevalence, any modern method is the percentage of all women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.